Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michael S Korenfeld"'
Autor:
Jason Bacharach, Robert Smyth-Medina, Shane R Kannarr, David Wirta, Michael S Korenfeld, Charles B. Slonim, Mark Jaros, Shane Foster
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Purpose An oxymetazoline 0.1% ophthalmic solution was recently approved for treatment of acquired blepharoptosis in adults. This study’s objective was to evaluate the safety profile of oxymetazoline 0.1% when administered once daily for 14–84 day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4e23d71c87b1eb0197bf4e293f138e
https://doi.org/10.2147/opth.s322326
https://doi.org/10.2147/opth.s322326
Autor:
Michael S Korenfeld, David G Evans, Stella M Robertson, Steven H Rauchman, Bee-Lian Chen, William H. Burns, Jerry M. Stein, Subha Venkataraman, Mark Wuttke, Kenneth N Sall
Publikováno v:
Eye
Objectives This study evaluated the safety of topical lipoic acid choline ester (UNR844, 1.5%) ophthalmic solution and its efficacy in improving distance-corrected near visual acuity (DCNVA) in subjects with presbyopia. Subjects and methods This was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7b68604b13a4380843f2f34269216c
https://doi.org/10.1038/s41433-020-01391-z
https://doi.org/10.1038/s41433-020-01391-z
Autor:
Michael B. Raizman, C. Stephen Foster, Christopher Lievens, Michael S Korenfeld, Barbara M Wirostko, John D. Sheppard, Sunir J. Garg, Lisa A Brandano
Publikováno v:
American Journal of Ophthalmology. 211:76-86
Purpose To evaluate the safety and efficacy of dexamethasone phosphate ophthalmic solution (EGP-437) delivered by a transscleral iontophoresis delivery system (EyeGate II) compared to that of topical prednisolone acetate 1% (PA 1%) in subjects with n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2232f6b691eb4b6baed8eab18d2da320
https://doi.org/10.1016/j.ajo.2019.10.032
https://doi.org/10.1016/j.ajo.2019.10.032
Autor:
Jason Bacharach, Robert Smyth-Medina, Charles B. Slonim, Shane R Kannarr, David Wirta, Shane Foster, Mark Jaros, Michael S Korenfeld
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Jason Bacharach,1 David L Wirta,2 Robert Smyth-Medina,3 Michael S Korenfeld,4 Shane R Kannarr,5 Shane Foster,6 Mark J Jaros,7 Charles B Slonim8 1North Bay Eye Associates, Petaluma, CA, USA; 2Aesthetic Eye Care Institute & Eye Research Foundation, New
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52fd06504f2314977a37588e2e02ae3b
https://www.dovepress.com/rapid-and-sustained-eyelid-elevation-in-acquired-blepharoptosis-with-o-peer-reviewed-fulltext-article-OPTH
https://www.dovepress.com/rapid-and-sustained-eyelid-elevation-in-acquired-blepharoptosis-with-o-peer-reviewed-fulltext-article-OPTH
Autor:
Albert S. Khouri, Janet B. Serle, Jason Bacharach, Dale W. Usner, Richard A. Lewis, Puiwah Braswell, Casey C. Kopczynski, Theresa Heah, Robert Benza, John W. Boyle, Michelle Butler, Leonard Robert Cacioppo, Jose F. Cardona, Valerie A. Colborn, Douglas G. Day, David T. Douglass, Sherif M. El-Harazi, Deepta Ghate, Carl Hartman, Robert F. Haverly, Barry Katzman, Max Kim, Edward Y. Koo, Michael S. Korenfeld, Bradley Kwapiszeski, Lydia Lane, Christopher Lin, Andrew Gardner Logan, Jeffrey Raymond Lozier, Henry McQuirter, Thomas K. Mundorf, Kenneth Olander, Richard J. Ou, Gregory J. Panzo, James H. Peace, Eugene E. Protzko, Robert Ritch, Kenneth Sall, Barry A. Schechter, Samuel Eric Seltzer, Pankajkumar G. Shah, Elizabeth Sharpe, Philip Lee Shettle, David G. Shulman, Inder Paul Singh, Stacy R. Smith, Stephen E. Smith, Robert John Smyth-Medina, Robert C. Sorenson, Richard Sturm, Gregory M. Sulkowski, James D. Sutton, Michael Tepedino, Julie Tsai, Carl B. Tubbs, David B. Tukel, Thomas Richard Walters, David L. Wirta
Publikováno v:
American Journal of Ophthalmology. 204:97-104
To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID).Double-masked, randomized, phase 3, noninferiority study.Patients with open-angle glaucoma or ocular hypertension (unme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::432a3f4da9a8f60609010d2756b0ba10
https://doi.org/10.1016/j.ajo.2019.03.002
https://doi.org/10.1016/j.ajo.2019.03.002
Autor:
Kelly K. Nichols, Ken Sall, Michael S Korenfeld, David J. Evans, Damien F. Goldberg, Gary N. Foulks, Susan Coultas, Kim Brazzell
Publikováno v:
Cornea. 40(5)
Purpose The safety of KPI-121 0.25%, an ophthalmic nanoparticle suspension of loteprednol etabonate, was evaluated in subjects with dry eye disease (DED) in one phase 2 and three phase 3 randomized trials of similar design. Methods Adults with DED re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3093fca3731aa89b1371425415281c
https://pubmed.ncbi.nlm.nih.gov/32826644
https://pubmed.ncbi.nlm.nih.gov/32826644
Autor:
Kenneth N Sall, Michael H Goldstein, Todd A. Durham, Damien F. Goldberg, Jay Rubin, Marc Abrams, Jennifer Agahigian, Eric Furfine, Joseph R. Martel, John D. Sheppard, Michael S Korenfeld, Joseph Tauber
Publikováno v:
Eye & Contact Lens: Science & Clinical Practice. 43:287-296
Isunakinra, formerly known as EBI-005, is a novel interleukin (IL)-1 receptor inhibitor developed for topical treatment of patients with dry eye disease (DED). This phase 1b/2a multicenter, double-masked, randomized, vehicle controlled environmental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e347c1a5df0409e1e57fabae2ce3ec7
https://doi.org/10.1097/icl.0000000000000276
https://doi.org/10.1097/icl.0000000000000276
Autor:
David K Dueker, Michael S Korenfeld
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Purpose To describe a noninvasive instrument that estimates intraocular pressure during episodes of external globe compression and to demonstrate the accuracy and reliability of this device by comparing it to the intraocular pressures simultaneously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50bac69d1fe40af1db56ab503cd341fd
http://europepmc.org/articles/PMC4772763
http://europepmc.org/articles/PMC4772763
Autor:
Michael S. Korenfeld, Shane R Kannarr, Robert Smyth-Medina, Shane Foster, David L. Wirta, Mark Jaros, Charles B. Slonim
Publikováno v:
JAMA Ophthalmol
IMPORTANCE: Treatment of acquired blepharoptosis (ptosis) is currently limited to surgical intervention. OBJECTIVE: To examine the efficacy and safety of oxymetazoline hydrochloride, 0.1%, ophthalmic solution (oxymetazoline, 0.1%) in participants wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444b86898510365c83e1bffa260f45c4
https://doi.org/10.1001/jamaophthalmol.2020.3812
https://doi.org/10.1001/jamaophthalmol.2020.3812
Autor:
Michael S Korenfeld
Publikováno v:
Expert Review of Ophthalmology. 3:619-625
Ophthalmic surgery has evolved substantially during the last 40 years to include minimally invasive procedures and premium intraocular lens implantation. Patients and physicians who invest in such advanced technology, materials and procedures expect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::752b68f017c1e7935448ff60458912ec
https://doi.org/10.1586/17469899.3.6.619
https://doi.org/10.1586/17469899.3.6.619